Clinical complete response after trastuzumab deruxtecan 6th-line treatment for postoperative gastric cancer recurrence: a case report.

Erika YamadaKenichi IwasakiEdward BarrogaToru SakuraiMasaya EnomotoYota ShimodaJunichi MazakiHiroshi KuwabaraAkihiro HoshinoYutaka HayashiTetsuo IshizakiYuichi Nagakawa

Published in: Surgical case reports (2024)

We report the apparent first case of postoperative gastric cancer recurrence successfully treated with TDXD, achieving clinical CR with TDXD as a 6th-line treatment.

Keyphrases

patients undergoing
magnetic resonance
contrast enhanced